{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:10:00Z","timestamp":1789704600668,"version":"4.0.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Key Projects of Higher Education Institutions in Henan Province","award":["24B320005"],"award-info":[{"award-number":["24B320005"]}]},{"name":"Henan Provincial Science and Technology Key R&D Project","award":["252102310109"],"award-info":[{"award-number":["252102310109"]}]},{"name":"Henan Provincial Soft Science Research Program","award":["252400410244"],"award-info":[{"award-number":["252400410244"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04403-2","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:53:27Z","timestamp":1782845607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell-marker-based subtyping and multi-level analyses uncover the prognostic effects, dysregulations and therapeutic indicative potential of an eight-gene signature in lung adenocarcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiuzhi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenke","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanke","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"1","key":"4403_CR1","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4403_CR2","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.1038\/s41467-024-47606-9","volume":"15","author":"S Hobor","year":"2024","unstructured":"Hobor S, Al Bakir M, Hiley CT, Skrzypski M, Frankell AM, Bakker B, Watkins TBK, Markovets A, Dry JR, Brown AP, et al. Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling. Nat Commun. 2024;15(1):4871.","journal-title":"Nat Commun"},{"issue":"1","key":"4403_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41698-024-00569-y","volume":"8","author":"L Sun","year":"2024","unstructured":"Sun L, Guo W, Guo L, Chen X, Zhou H, Yan S, Zhao G, Bao H, Wu X, Shao Y, et al. Molecular landscape and multi-omic measurements of heterogeneity in fetal adenocarcinoma of the lung. NPJ precision Oncol. 2024;8(1):99.","journal-title":"NPJ precision Oncol"},{"issue":"1","key":"4403_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12943-025-02333-7","volume":"24","author":"B Liu","year":"2025","unstructured":"Liu B, Tao W, Zhou X, Xu LD, Luo Y, Yang X, Min Q, Huang M, Zhu Y, Cui X, et al. Multi\u2013omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinoma. Mol Cancer. 2025;24(1):129.","journal-title":"Mol Cancer"},{"key":"4403_CR5","doi-asserted-by":"crossref","unstructured":"Banerjee A, Vathiotis I, Halder D, Sen U, Wang X, Shields MD, Veluswamy RR, Syrigos K, Hirsch FR, Sen T. Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity. J Thorac oncology. 2025;20(11):1582-1593.","DOI":"10.1016\/j.jtho.2025.06.012"},{"issue":"1","key":"4403_CR6","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1038\/s41467-024-48700-8","volume":"15","author":"M De Zuani","year":"2024","unstructured":"De Zuani M, Xue H, Park JS, Dentro SC, Seferbekova Z, Tessier J, Curras-Alonso S, Hadjipanayis A, Athanasiadis EI, Gerstung M, et al. Single-cell and spatial transcriptomics analysis of non-small cell lung cancer. Nat Commun. 2024;15(1):4388.","journal-title":"Nat Commun"},{"issue":"6","key":"4403_CR7","doi-asserted-by":"publisher","first-page":"114286","DOI":"10.1016\/j.celrep.2024.114286","volume":"43","author":"B Kim","year":"2024","unstructured":"Kim B, Zhang S, Huang Y, Ko KP, Jung YS, Jang J, Zou G, Zhang J, Jun S, Kim KB, et al. CRACD loss induces neuroendocrine cell plasticity of lung adenocarcinoma. Cell Rep. 2024;43(6):114286.","journal-title":"Cell Rep"},{"issue":"1","key":"4403_CR8","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41467-021-22801-0","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu F, Fan J, He Y, Xiong A, Yu J, Li Y, Zhang Y, Zhao W, Zhou F, Li W, et al. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer. Nat Commun. 2021;12(1):2540.","journal-title":"Nat Commun"},{"issue":"28","key":"4403_CR9","doi-asserted-by":"publisher","first-page":"e2322203121","DOI":"10.1073\/pnas.2322203121","volume":"121","author":"S Zaidi","year":"2024","unstructured":"Zaidi S, Park J, Chan JM, Roudier MP, Zhao JL, Gopalan A, Wadosky KM, Patel RA, Sayar E, Karthaus WR, et al. Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies. Proc Natl Acad Sci USA. 2024;121(28):e2322203121.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4403_CR10","doi-asserted-by":"publisher","first-page":"2371556","DOI":"10.1080\/2162402X.2024.2371556","volume":"13","author":"Y Sugita","year":"2024","unstructured":"Sugita Y, Muraoka D, Demachi-Okamura A, Komuro H, Masago K, Sasaki E, Fukushima Y, Matsui T, Shinohara S, Takahashi Y, et al. Candidate tumor-specific CD8(+) T cell subsets identified in the malignant pleural effusion of advanced lung cancer patients by single-cell analysis. Oncoimmunology. 2024;13(1):2371556.","journal-title":"Oncoimmunology"},{"issue":"6","key":"4403_CR11","doi-asserted-by":"publisher","first-page":"e1011309","DOI":"10.1371\/journal.pgen.1011309","volume":"20","author":"Y Kong","year":"2024","unstructured":"Kong Y, Li C, Liu J, Wu S, Zhang M, Allison DB, Hassan F, He D, Wang X, Mao F, et al. Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD. PLoS Genet. 2024;20(6):e1011309.","journal-title":"PLoS Genet"},{"issue":"8004","key":"4403_CR12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41586-024-07113-9","volume":"627","author":"G Han","year":"2024","unstructured":"Han G, Sinjab A, Rahal Z, Lynch AM, Treekitkarnmongkol W, Liu Y, Serrano AG, Feng J, Liang K, Khan K, et al. An atlas of epithelial cell states and plasticity in lung adenocarcinoma. Nature. 2024;627(8004):656\u201363.","journal-title":"Nature"},{"issue":"1","key":"4403_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1954.1","volume":"8","author":"P Armitage","year":"1954","unstructured":"Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer. 1954;8(1):1\u201312.","journal-title":"Br J Cancer"},{"issue":"Pt 2","key":"4403_CR14","doi-asserted-by":"publisher","first-page":"132797","DOI":"10.1016\/j.ijbiomac.2024.132797","volume":"272","author":"A Li","year":"2024","unstructured":"Li A, Zhang K, Zhou J, Li M, Fan M, Gao H, Ma R, Gao L, Chen M. Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma. Int J Biol Macromol. 2024;272(Pt 2):132797.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"4403_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s13167-024-00366-4","volume":"15","author":"N Li","year":"2024","unstructured":"Li N, Jia W, Wang J, Shao Q, Feng X, Li Z, Sun W, Kang M, Hu D, Xing L, et al. Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach. EPMA J. 2024;15(2):345\u201373.","journal-title":"EPMA J"},{"key":"4403_CR16","doi-asserted-by":"crossref","unstructured":"Wei Z, Zhao Y, Cai J, Xie Y. The Nucleolar Protein C1orf131 Is a Novel Gene Involved in the Progression of Lung Adenocarcinoma Cells through the AKT Signalling Pathway. Int J Mol Sci. 2024;25(12):6381.","DOI":"10.3390\/ijms25126381"},{"key":"4403_CR17","doi-asserted-by":"publisher","first-page":"1587947","DOI":"10.3389\/fimmu.2025.1587947","volume":"16","author":"X Yin","year":"2025","unstructured":"Yin X, Jiang Y, Huang J, Luo J, Xu L, Yang Q. The prognostic model based on tumor-associated neutrophils contributes to the stromal landscape and influences metabolic reprogramming in colorectal cancer. Front Immunol. 2025;16:1587947.","journal-title":"Front Immunol"},{"issue":"1","key":"4403_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-025-01453-5","volume":"17","author":"Q Luo","year":"2025","unstructured":"Luo Q, Teschendorff AE. Cell-type-specific subtyping of epigenomes improves prognostic stratification of cancer. Genome Med. 2025;17(1):34.","journal-title":"Genome Med"},{"issue":"40","key":"4403_CR19","doi-asserted-by":"publisher","first-page":"6473","DOI":"10.3748\/wjg.v12.i40.6473","volume":"12","author":"Y Takahara","year":"2006","unstructured":"Takahara Y, Takahashi M, Wagatsuma H, Yokoya F, Zhang QW, Yamaguchi M, Aburatani H, Kawada N. Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis. World J Gastroenterol. 2006;12(40):6473\u201399.","journal-title":"World J Gastroenterol"},{"key":"4403_CR20","doi-asserted-by":"crossref","unstructured":"Ning W, Qiao N, Zhou L, Li Z, Zhang L, Song X, Chen S. Integrative Multiscale Analysis Reveals EFNA1-Driven Immune Remodeling Promotes Colorectal Cancer Lymph Node Metastasis. Hum Mutat 2026, 2026:8553028.","DOI":"10.1155\/humu\/8553028"},{"key":"4403_CR21","doi-asserted-by":"publisher","first-page":"1710915","DOI":"10.3389\/fimmu.2025.1710915","volume":"16","author":"B Shen","year":"2025","unstructured":"Shen B, Jiang J, Zhang X, Yi C, Liu J, Li Z, Ma Y. Integrated single-cell and bulk transcriptomic analysis reveals shared pathogenesis and prognostic biomarkers in breast and thyroid cancers. Front Immunol. 2025;16:1710915.","journal-title":"Front Immunol"},{"key":"4403_CR22","doi-asserted-by":"crossref","unstructured":"Zhang J, Zheng L, Yu Z, Chen Y, Jiang F, Zhang Z, Li T, Zhao H, Li Y, Li F. Single-cell and Bulk RNA-Seq Analyses Reveal TOMM7-mediated Multi-cell Death Mechanisms Driving Muscle-invasive Bladder Cancer Progression. Recent Pat Anticancer Drug Discov. 2026. (Online ahead of print, no volume\/page numbers have been assigned.)","DOI":"10.2174\/0115748928396718251104075645"},{"issue":"1","key":"4403_CR23","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1038\/s41467-025-57364-x","volume":"16","author":"H Su","year":"2025","unstructured":"Su H, Chen L, Wu J, Cheng Z, Li J, Ren Y, Xu J, Dang Y, Zheng M, Cao Y, et al. Proteogenomic characterization reveals tumorigenesis and progression of lung cancer manifested as subsolid nodules. Nat Commun. 2025;16(1):2414.","journal-title":"Nat Commun"},{"issue":"25","key":"4403_CR24","first-page":"e2501336","volume":"12","author":"D Zhang","year":"2025","unstructured":"Zhang D, Peng K, Xu H, Chen Y, Wang J. Proteomics-Empowered Microfluidic-SERS Immunoassay for Identifying and Detecting Biomarkers of Micropapillary Lung Adenocarcinoma. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2025;12(25):e2501336.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"issue":"1","key":"4403_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12967-024-05123-9","volume":"22","author":"H Liu","year":"2024","unstructured":"Liu H, Sima X, Xiao B, Gulizeba H, Zhao S, Zhou T, Huang Y. Integrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cell-related regulon predicting neoadjuvant immunotherapy response across cancers. J translational Med. 2024;22(1):486.","journal-title":"J translational Med"},{"issue":"1","key":"4403_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12931-024-02870-7","volume":"25","author":"Z Liu","year":"2024","unstructured":"Liu Z, Lu Q, Zhang Z, Feng Q, Wang X. TMPRSS2 is a tumor suppressor and its downregulation promotes antitumor immunity and immunotherapy response in lung adenocarcinoma. Respir Res. 2024;25(1):238.","journal-title":"Respir Res"},{"key":"4403_CR27","doi-asserted-by":"crossref","unstructured":"Mao S, Wang Y, Chao N, Zeng L, Zhang L. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma. Cell Oncol (Dordrecht). 2024;47(5):1697-1713.","DOI":"10.1007\/s13402-024-00948-4"},{"key":"4403_CR28","doi-asserted-by":"publisher","first-page":"1273422","DOI":"10.3389\/fimmu.2023.1273422","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Yin Z, Luan Z, Zhang C, Wang Y, Zhang K, Chen F, Yang Z, Tian Y. Comprehensive analyses for the coagulation and macrophage-related genes to reveal their joint roles in the prognosis and immunotherapy of lung adenocarcinoma patients. Front Immunol. 2023;14:1273422.","journal-title":"Front Immunol"},{"issue":"9","key":"4403_CR29","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.7150\/jca.94588","volume":"15","author":"M Shengping","year":"2024","unstructured":"Shengping M, Luyao W, Yiluo X, Huili C, Ruijie W, Ge S, Xiaojing W, Chaoqun L. Copper-binding protein modelling by single-cell transcriptome and Bulk transcriptome to predict overall survival in lung adenocarcinoma patients. J Cancer. 2024;15(9):2659\u201377.","journal-title":"J Cancer"},{"key":"4403_CR30","doi-asserted-by":"publisher","first-page":"108078","DOI":"10.1016\/j.compbiomed.2024.108078","volume":"171","author":"S Sun","year":"2024","unstructured":"Sun S, Wang K, Guo D, Zheng H, Liu Y, Shen H, Du J. Identification of the key DNA damage response genes for predicting immunotherapy and chemotherapy efficacy in lung adenocarcinoma based on bulk, single-cell RNA sequencing, and spatial transcriptomics. Comput Biol Med. 2024;171:108078.","journal-title":"Comput Biol Med"},{"key":"4403_CR31","doi-asserted-by":"publisher","first-page":"e17545","DOI":"10.7717\/peerj.17545","volume":"12","author":"X Wang","year":"2024","unstructured":"Wang X, Chen J, Li C, Liu Y, Chen S, Lv F, Lan K, He W, Zhu H, Xu L, et al. Integrated bulk and single-cell RNA sequencing identifies an aneuploidy-based gene signature to predict sensitivity of lung adenocarcinoma to traditional chemotherapy drugs and patients\u2019 prognosis. PeerJ. 2024;12:e17545.","journal-title":"PeerJ"},{"issue":"1","key":"4403_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13059-025-03559-w","volume":"26","author":"J Yates","year":"2025","unstructured":"Yates J, Kraft A, Boeva V. Filtering cells with high mitochondrial content depletes viable metabolically altered malignant cell populations in cancer single-cell studies. Genome Biol. 2025;26(1):91.","journal-title":"Genome Biol"},{"issue":"18","key":"4403_CR33","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1158\/0008-5472.CAN-22-2593","volume":"83","author":"H Wu","year":"2023","unstructured":"Wu H, Leng X, Liu Q, Mao T, Jiang T, Liu Y, Li F, Cao C, Fan J, Chen L, et al. Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell Carcinoma. Cancer Res. 2023;83(18):3131\u201344.","journal-title":"Cancer Res"},{"issue":"1","key":"4403_CR34","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1038\/s41467-023-39750-5","volume":"14","author":"ZQ Liu","year":"2023","unstructured":"Liu ZQ, Dai H, Yao L, Chen WF, Wang Y, Ma LY, Li XQ, Lin SL, He MJ, Gao PT, et al. A single-cell transcriptional landscape of immune cells shows disease-specific changes of T cell and macrophage populations in human achalasia. Nat Commun. 2023;14(1):4685.","journal-title":"Nat Commun"},{"issue":"7","key":"4403_CR35","doi-asserted-by":"publisher","first-page":"e2204565","DOI":"10.1002\/advs.202204565","volume":"10","author":"Y Jia","year":"2023","unstructured":"Jia Y, Zhang B, Zhang C, Kwong DL, Chang Z, Li S, Wang Z, Han H, Li J, Zhong Y, et al. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell Carcinoma. Adv Sci (Weinh). 2023;10(7):e2204565.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"4403_CR36","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1038\/s41467-022-32552-1","volume":"13","author":"D Saul","year":"2022","unstructured":"Saul D, Kosinsky RL, Atkinson EJ, Doolittle ML, Zhang X, LeBrasseur NK, Pignolo RJ, Robbins PD, Niedernhofer LJ, Ikeno Y, et al. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat Commun. 2022;13(1):4827.","journal-title":"Nat Commun"},{"issue":"10","key":"4403_CR37","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"4403_CR38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12935-024-03242-3","volume":"24","author":"X Zhang","year":"2024","unstructured":"Zhang X, Xiao Z, Zhang X, Li N, Sun T, Zhang J, Kang C, Fan S, Dai L, Liu X. Signature construction and molecular subtype identification based on liver-specific genes for prediction of prognosis, immune activity, and anti-cancer drug sensitivity in hepatocellular carcinoma. Cancer Cell Int. 2024;24(1):78.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"4403_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41419-018-0272-z","volume":"9","author":"JM Mellado-Gil","year":"2018","unstructured":"Mellado-Gil JM, Fuente-Mart\u00edn E, Lorenzo PI, Cobo-Vuilleumier N, L\u00f3pez-Noriega L, Mart\u00edn-Montalvo A, G\u00f3mez IGH, Ceballos-Ch\u00e1vez M, G\u00f3mez-Jaramillo L, Campos-Caro A, et al. The type 2 diabetes-associated HMG20A gene is mandatory for islet beta cell functional maturity. Cell Death Dis. 2018;9(3):279.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4403_CR40","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cell.2020.05.043","volume":"182","author":"JY Xu","year":"2020","unstructured":"Xu JY, Zhang C, Wang X, Zhai L, Ma Y, Mao Y, Qian K, Sun C, Liu Z, Jiang S, et al. Integrative Proteomic Characterization of Human Lung Adenocarcinoma. Cell. 2020;182(1):245\u2013e261217.","journal-title":"Cell"},{"issue":"1","key":"4403_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12967-024-04860-1","volume":"22","author":"H Yuan","year":"2024","unstructured":"Yuan H, Mao X, Yan Y, Huang R, Zhang Q, Zeng Y, Bao M, Dai Y, Fang B, Mi J, et al. Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer. J translational Med. 2024;22(1):48.","journal-title":"J translational Med"},{"issue":"D1","key":"4403_CR42","doi-asserted-by":"publisher","first-page":"D1345","DOI":"10.1093\/nar\/gkaf1230","volume":"54","author":"F Elloumi","year":"2026","unstructured":"Elloumi F, Reinhold WC, Varma S, Wang Y, Kinali M, Arakawa Y, Inoue Y, Aladjem MI, Pommier Y, Luna A. CellMiner cross-database (CellMinerCDB) version 2.2 for explorations of patient-derived cancer cell line pharmacogenomics. Nucleic Acids Res. 2026;54(D1):D1345\u201354.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"4403_CR43","doi-asserted-by":"publisher","first-page":"e1013384","DOI":"10.1371\/journal.pcbi.1013384","volume":"21","author":"L Lin","year":"2025","unstructured":"Lin L, Lapi F, Galuzzi BG, Vanoni M, Alberghina L, Damiani C. Mechanistically informed machine learning links non-canonical TCA cycle activity to Warburg metabolism and hallmarks of malignancy. PLoS Comput Biol. 2025;21(12):e1013384.","journal-title":"PLoS Comput Biol"},{"issue":"24","key":"4403_CR44","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1016\/j.molcel.2025.11.022","volume":"85","author":"S Liu","year":"2025","unstructured":"Liu S, Li Q, Cao M, Zhao ZB, Liu C, Zhen Z, Ren J, Liu C, Ruan D, Zhang L, et al. The TIM22 carrier translocase supports cell proliferation by facilitating mitochondrial iron uptake for Fe-S biogenesis. Mol Cell. 2025;85(24):4587\u2013e46014587.","journal-title":"Mol Cell"},{"issue":"1","key":"4403_CR45","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1186\/s12885-025-14150-8","volume":"25","author":"X Zhang","year":"2025","unstructured":"Zhang X, Wang Z, Zhao Y, Ye H, Li T, Wang H, Sun G, Liang F, Dai L, Wang P, et al. Multi-omics analysis unveils a four-gene prognostic signature in esophageal squamous carcinoma and the therapeutic potential of PKP1. BMC Cancer. 2025;25(1):777.","journal-title":"BMC Cancer"},{"key":"4403_CR46","doi-asserted-by":"publisher","first-page":"217941","DOI":"10.1016\/j.canlet.2025.217941","volume":"631","author":"K Ishiguro","year":"2025","unstructured":"Ishiguro K, Kitajima H, Niinuma T, Maruyama R, Tsukahara T, Hirohashi Y, Takaya A, Kumegawa K, Yoshido A, Sekiguchi S, et al. DOT1L inhibition reprograms innate immunity to potentiate immunomodulatory drug responses in multiple myeloma. Cancer Lett. 2025;631:217941.","journal-title":"Cancer Lett"},{"issue":"1","key":"4403_CR47","doi-asserted-by":"publisher","first-page":"10390","DOI":"10.1038\/s41467-024-54771-4","volume":"15","author":"Z Cai","year":"2024","unstructured":"Cai Z, Apolin\u00e1rio S, Bai\u00e3o AR, Pacini C, Sousa MD, Vinga S, Reddel RR, Robinson PJ, Garnett MJ, Zhong Q, et al. Synthetic augmentation of cancer cell line multi-omic datasets using unsupervised deep learning. Nat Commun. 2024;15(1):10390.","journal-title":"Nat Commun"},{"issue":"1","key":"4403_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","volume":"12","author":"J Fu","year":"2020","unstructured":"Fu J, Li K, Zhang W, Wan C, Zhang J, Jiang P, Liu XS. Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 2020;12(1):21.","journal-title":"Genome Med"},{"issue":"26","key":"4403_CR49","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1038\/onc.2011.20","volume":"30","author":"LP Chen","year":"2011","unstructured":"Chen LP, Lai YD, Li DC, Zhu XN, Yang P, Li WX, Zhu W, Zhao J, Li XD, Xiao YM, et al. \u03b14 is highly expressed in carcinogen-transformed human cells and primary human cancers. Oncogene. 2011;30(26):2943\u201353.","journal-title":"Oncogene"},{"issue":"5","key":"4403_CR50","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00204-015-1551-4","volume":"90","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhang Z, Wang H, Zhang Y, Ji M, Xu H, Wang C, Sun Z, Gao W, Wang SL. miR-138-1* regulates aflatoxin B1-induced malignant transformation of BEAS-2B cells by targeting PDK1. Arch Toxicol. 2016;90(5):1239\u201349.","journal-title":"Arch Toxicol"},{"issue":"2","key":"4403_CR51","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1158\/2159-8290.CD-23-0289","volume":"14","author":"Z Li","year":"2024","unstructured":"Li Z, Zhuang X, Pan CH, Yan Y, Thummalapalli R, Hallin J, Torborg S, Singhal A, Chang JC, Manchado E, et al. Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma. Cancer Discov. 2024;14(2):308\u201325.","journal-title":"Cancer Discov"},{"issue":"2","key":"4403_CR52","doi-asserted-by":"publisher","first-page":"e1573","DOI":"10.1002\/ctm2.1573","volume":"14","author":"L Xie","year":"2024","unstructured":"Xie L, Kong H, Yu J, Sun M, Lu S, Zhang Y, Hu J, Du F, Lian Q, Xin H, et al. Spatial transcriptomics reveals heterogeneity of histological subtypes between lepidic and acinar lung adenocarcinoma. Clin translational Med. 2024;14(2):e1573.","journal-title":"Clin translational Med"},{"key":"4403_CR53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13578-018-0242-2","volume":"8","author":"L Fei","year":"2018","unstructured":"Fei L, Xu H. Role of MCM2-7 protein phosphorylation in human cancer cells. Cell bioscience. 2018;8:43.","journal-title":"Cell bioscience"},{"key":"4403_CR54","doi-asserted-by":"crossref","unstructured":"Sonntag R, Penners C, Kohlhepp M, Haas U, Lambertz D, Kroh A, Cramer T, Ticconi F, Costa IG, Tacke F et al. Cyclin E1 in Murine and Human Liver Cancer: A Promising Target for Therapeutic Intervention during Tumour Progression. Cancers 2021, 13(22).","DOI":"10.3390\/cancers13225680"},{"issue":"7","key":"4403_CR55","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.ccell.2023.05.006","volume":"41","author":"LI Prieto","year":"2023","unstructured":"Prieto LI, Sturmlechner I, Graves SI, Zhang C, Goplen NP, Yi ES, Sun J, Li H, Baker DJ. Senescent alveolar macrophages promote early-stage lung tumorigenesis. Cancer Cell. 2023;41(7):1261\u2013e12751266.","journal-title":"Cancer Cell"},{"issue":"6859","key":"4403_CR56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105\u201311.","journal-title":"Nature"},{"issue":"1","key":"4403_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","volume":"373","author":"J Larkin","year":"2015","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, Schadendorf D, Dummer R, Smylie M, Rutkowski P, et al. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med. 2015;373(1):23\u201334.","journal-title":"N Engl J Med"},{"issue":"26","key":"4403_CR58","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, Daud A, Carlino MS, McNeil C, Lotem M, et al. Pembrolizumab versus Ipilimumab in Advanced Melanoma. N Engl J Med. 2015;372(26):2521\u201332.","journal-title":"N Engl J Med"},{"issue":"1","key":"4403_CR59","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13046-023-02846-3","volume":"42","author":"B Palermo","year":"2023","unstructured":"Palermo B, Franzese O, Frisullo G, D\u2019Ambrosio L, Panetta M, Campo G, D\u2019Andrea D, Sperduti I, De Nicola F, Goeman F, et al. CD28\/PD1 co-expression: dual impact on CD8(+) T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients\u2019 survival and ICB response. J experimental Clin cancer research: CR. 2023;42(1):287.","journal-title":"J experimental Clin cancer research: CR"},{"key":"4403_CR60","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.lungcan.2020.12.026","volume":"152","author":"B Abbar","year":"2021","unstructured":"Abbar B, De Castelbajac V, Gougis P, Assoun S, Pluvy J, Tesmoingt C, Th\u00e9ou-Anton N, Cazes A, Namour C, Khalil A, et al. Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors. Lung cancer (Amsterdam Netherlands). 2021;152:109\u201318.","journal-title":"Lung cancer (Amsterdam Netherlands)"},{"issue":"1","key":"4403_CR61","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","volume":"23","author":"X Lin","year":"2024","unstructured":"Lin X, Kang K, Chen P, Zeng Z, Li G, Xiong W, Yi M, Xiang B. Regulatory mechanisms of PD-1\/PD-L1 in cancers. Mol Cancer. 2024;23(1):108.","journal-title":"Mol Cancer"},{"key":"4403_CR62","doi-asserted-by":"crossref","unstructured":"Ducellier S, Demeules M, Letribot B, Gaetani M, Michaudel C, Sokol H, Hamze A, Alami M, Nascimento M, Apcher S. Dual molecule targeting HDAC6 leads to intratumoral CD4\u2009+\u2009cytotoxic lymphocytes recruitment through MHC-II upregulation on lung cancer cells. J Immunother Cancer. 2024;12(4):e007588.","DOI":"10.1136\/jitc-2023-007588"},{"key":"4403_CR63","doi-asserted-by":"publisher","first-page":"112495","DOI":"10.1016\/j.intimp.2024.112495","volume":"137","author":"Y Yu","year":"2024","unstructured":"Yu Y, Liu M, Wang Z, Liu Y, Yao M, Wang L, Zhong L. Identification of oxidative stress signatures of lung adenocarcinoma and prediction of patient prognosis or treatment response with single-cell RNA sequencing and bulk RNA sequencing data. Int Immunopharmacol. 2024;137:112495.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"4403_CR64","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.21037\/tlcr-24-309","volume":"13","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Hammad B, Huang H, Zhang C, Xiao B, Liu L, Liu Q, Liang H, Zhao Z, Gao Y. Bioinformatics analysis of an immunotherapy responsiveness-related gene signature in predicting lung adenocarcinoma prognosis. Translational lung cancer Res. 2024;13(6):1277\u201395.","journal-title":"Translational lung cancer Res"},{"key":"4403_CR65","doi-asserted-by":"publisher","first-page":"108692","DOI":"10.1016\/j.compbiomed.2024.108692","volume":"178","author":"M Zhou","year":"2024","unstructured":"Zhou M, Li H, Gao B, Zhao Y. The prognostic impact of pathogenic stromal cell-associated genes in lung adenocarcinoma. Comput Biol Med. 2024;178:108692.","journal-title":"Comput Biol Med"},{"issue":"6","key":"4403_CR66","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41419-024-06853-w","volume":"15","author":"Y Yuan","year":"2024","unstructured":"Yuan Y, Hao L, Huang JS, Zhao FY, Ju YH, Wang JM, Zhang T, Li BQ, Yu ZW. Promotion of stem cell-like phenotype of lung adenocarcinoma by FAM83A via stabilization of ErbB2. Cell Death Dis. 2024;15(6):460.","journal-title":"Cell Death Dis"},{"issue":"10","key":"4403_CR67","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.7150\/ijbs.59939","volume":"17","author":"D Zhang","year":"2021","unstructured":"Zhang D, Jiang Q, Ge X, Shi Y, Ye T, Mi Y, Xie T, Li Q, Ye Q. RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK\/c-Jun pathway. Int J Biol Sci. 2021;17(10):2622\u201332.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"4403_CR68","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41388-024-03220-z","volume":"44","author":"H Li","year":"2025","unstructured":"Li H, Li Y, Zheng X, Chen F, Zhang S, Xu S, Mu Y, Shen W, Tong J, Chen H, et al. RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1. Oncogene. 2025;44(5):307\u201321.","journal-title":"Oncogene"},{"issue":"1","key":"4403_CR69","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1186\/s12967-023-04616-3","volume":"21","author":"Y Liu","year":"2023","unstructured":"Liu Y, Han T, Wu J, Zhou J, Guo J, Miao R, Xu Z, Xing Y, Bai Y, Hu D. SPOCK1, as a potential prognostic and therapeutic biomarker for lung adenocarcinoma, is associated with epithelial-mesenchymal transition and immune evasion. J translational Med. 2023;21(1):909.","journal-title":"J translational Med"},{"issue":"26","key":"4403_CR70","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1038\/s41388-021-01853-y","volume":"40","author":"J Wu","year":"2021","unstructured":"Wu J, Li L, Zhang H, Zhao Y, Zhang H, Wu S, Xu B. A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma. Oncogene. 2021;40(26):4413\u201324.","journal-title":"Oncogene"},{"issue":"10","key":"4403_CR71","doi-asserted-by":"publisher","first-page":"e1494677","DOI":"10.1080\/2162402X.2018.1494677","volume":"7","author":"X Li","year":"2018","unstructured":"Li X, Li J, Wu P, Zhou L, Lu B, Ying K, Chen E, Lu Y, Liu P. Smoker and non-smoker lung adenocarcinoma is characterized by distinct tumor immune microenvironments. Oncoimmunology. 2018;7(10):e1494677.","journal-title":"Oncoimmunology"},{"key":"4403_CR72","doi-asserted-by":"publisher","first-page":"828814","DOI":"10.3389\/fonc.2022.828814","volume":"12","author":"T Fan","year":"2022","unstructured":"Fan T, Liu Y, Liu H, Wang L, Tian H, Zheng Y, Zheng B, Xue L, Li C, He J. Transmembrane Protein-Based Risk Model and H3K4me3 Modification Characteristics in Lung Adenocarcinoma. Front Oncol. 2022;12:828814.","journal-title":"Front Oncol"},{"key":"4403_CR73","doi-asserted-by":"crossref","unstructured":"Siddhuraj P, Clausson CM, Sanden C, Alyamani M, Kadivar M, Marsal J, Wallengren J, Bjermer L, Erjef\u00e4lt JS. Lung Mast Cells Have a High Constitutive Expression of Carboxypeptidase A3 mRNA That Is Independent from Granule-Stored CPA3. Cells 2021, 10(2).","DOI":"10.3390\/cells10020309"},{"key":"4403_CR74","doi-asserted-by":"publisher","first-page":"1177847","DOI":"10.3389\/fimmu.2023.1177847","volume":"14","author":"J Shu","year":"2023","unstructured":"Shu J, Jiang J, Zhao G. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis. Front Immunol. 2023;14:1177847.","journal-title":"Front Immunol"},{"key":"4403_CR75","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.omtn.2022.11.019","volume":"30","author":"L Wang","year":"2022","unstructured":"Wang L, Liu W, Liu K, Wang L, Yin X, Bo L, Xu H, Lin S, Feng K, Zhou X, et al. The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis. Mol therapy Nucleic acids. 2022;30:633\u201347.","journal-title":"Mol therapy Nucleic acids"},{"issue":"8","key":"4403_CR76","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s41417-025-00928-2","volume":"32","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, An N, Zhang Q, Liu Y, Gu P, Zhao J, Pan W, Pu Q, Wen Z. SLC34A2 inhibits tumorigenesis and progression via upregulating LRRK2\/TTF-1\/SELENBP1 axis in lung adenocarcinoma. Cancer Gene Ther. 2025;32(8):870\u201383.","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"4403_CR77","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12929-015-0158-7","volume":"22","author":"Y Wang","year":"2015","unstructured":"Wang Y, Yang W, Pu Q, Yang Y, Ye S, Ma Q, Ren J, Cao Z, Zhong G, Zhang X, et al. The effects and mechanisms of SLC34A2 in tumorigenesis and progression of human non-small cell lung cancer. J Biomed Sci. 2015;22(1):52.","journal-title":"J Biomed Sci"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04403-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04403-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04403-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:01:06Z","timestamp":1789704066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04403-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4403"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04403-2","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"319"}}